share_log

Intelligent Bio Solutions | CORRESP: CORRESP

Intelligent Bio Solutions | CORRESP: CORRESP

Intelligent Bio Solutions | CORRESP:信函
美股sec公告 ·  03/25 22:18
Moomoo AI 已提取核心信息
Intelligent Bio Solutions Inc., a Delaware corporation, has submitted a request to the U.S. Securities and Exchange Commission (SEC) for the acceleration of the effective date of its Registration Statement on Form S-3, initially filed under File No. 333-278025. The company has requested that the Registration Statement be declared effective at 5:00 P.M. Eastern Time on March 27, 2024. This request was made pursuant to Rule 461 of the Securities Act of 1933, as amended. The communication was officially signed by Spiro Sakiris, the Chief Financial Officer of Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc., a Delaware corporation, has submitted a request to the U.S. Securities and Exchange Commission (SEC) for the acceleration of the effective date of its Registration Statement on Form S-3, initially filed under File No. 333-278025. The company has requested that the Registration Statement be declared effective at 5:00 P.M. Eastern Time on March 27, 2024. This request was made pursuant to Rule 461 of the Securities Act of 1933, as amended. The communication was officially signed by Spiro Sakiris, the Chief Financial Officer of Intelligent Bio Solutions Inc.
特拉华州的一家公司Intelligent Bio Solutions Inc. 已向美国证券交易委员会(SEC)提交了一份申请,要求加快其S-3表格注册声明的生效日期,该声明最初以333-278025号文件提交。该公司已要求宣布注册声明于美国东部时间2024年3月27日下午 5:00 生效。该请求是根据经修订的1933年《证券法》第461条提出的。该信函由智能生物解决方案公司首席财务官斯皮罗·萨基里斯正式签署。
特拉华州的一家公司Intelligent Bio Solutions Inc. 已向美国证券交易委员会(SEC)提交了一份申请,要求加快其S-3表格注册声明的生效日期,该声明最初以333-278025号文件提交。该公司已要求宣布注册声明于美国东部时间2024年3月27日下午 5:00 生效。该请求是根据经修订的1933年《证券法》第461条提出的。该信函由智能生物解决方案公司首席财务官斯皮罗·萨基里斯正式签署。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息